ViroPharma Announces That Treatment With HCV-796 Reduces Hepatitis C Virus Levels
November 10, 2005 07:30 ET
|
ViroPharma Incorporated
EXTON, Pa., Nov. 10, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced preliminary results from a Phase 1b proof of concept study with HCV-796, an orally dosed hepatitis C...
ViroPharma Announces Additional Investment for Vancocin Supply
November 03, 2005 16:56 ET
|
ViroPharma Incorporated
EXTON, Pa., Nov. 3, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the amendment of its manufacturing agreement with Eli Lilly and Company (Lilly) (NYSE:LLY) in order to...
ViroPharma to Release 2005 Third Quarter and Nine Month Financial Results On November 7, 2005
November 01, 2005 09:00 ET
|
ViroPharma Incorporated
EXTON, Pa., Nov. 1, 2005 (PRIMEZONE) -- ViroPharma Incorporated's (Nasdaq:VPHM) third quarter and nine months 2005 financial results are expected to be released on Monday November 7, 2005, before the...
ViroPharma Announces Sponsorship of National Clostridium Difficile-Associated Disease Surveillance Project
October 10, 2005 12:48 ET
|
ViroPharma Incorporated
EXTON, Pa., Oct. 10, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that the company has provided an unrestricted educational grant supporting the 'Clostridium...
Symposium On Clostridium difficile Highlights Difficulties in Containment and Increasing Severity of Disease
October 06, 2005 16:31 ET
|
ViroPharma Incorporated
EXTON, Pa., Oct. 6, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the presentation of data by industry thought leaders on the changing epidemiology of Clostridium...
ViroPharma Responds to Epidemic of Severe Disease Caused By Clostridium Difficile
September 26, 2005 09:11 ET
|
ViroPharma Incorporated
EXTON, Pa., Sept. 26, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today reiterated that the company is engaged in efforts to meet the increased concerns of severe disease caused by an...
ViroPharma to Present at the 2005 UBS Global Life Sciences Conference
September 20, 2005 11:01 ET
|
ViroPharma Incorporated
EXTON, Pa., Sept. 20, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at 2005 UBS Global Life Sciences Conference, at 11:00 A.M. Eastern Time on Monday...
ViroPharma to Webcast 'Teach-In' On Clostridium Difficile Disease
September 12, 2005 13:35 ET
|
ViroPharma Incorporated
EXTON, Pa., Sept. 12, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) announced today that the company will provide an audio webcast of its 'Teach-in' for investors on Clostridium...
ViroPharma Incorporated Reports Second Quarter and Six-Month 2005 Financial Results
August 02, 2005 17:04 ET
|
ViroPharma Incorporated
EXTON, Pa., Aug. 2, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today its financial results for the second quarter and six-months ended June 30, 2005.
Net sales of...
ViroPharma to Release 2005 Second Quarter and Six Month Financial Results on August 2, 2005
July 26, 2005 09:35 ET
|
ViroPharma Incorporated
EXTON, Pa., July 26, 2005 (PRIMEZONE) -- ViroPharma Incorporated's (Nasdaq:VPHM) second quarter and six months 2005 financial results are expected to be released on Tuesday, August 2, 2005 after the...